NCT00240942View on ClinicalTrials.gov

Letrozole in the Treatment of Severe and Recurrent Endometriosis

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Severe and Recurrent Endometriosis
Interventions
DRUG

Letrozole

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY